Fragment‐based in silico design of SARS‐CoV‐2 main protease inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fragment‐based in silico design of SARS‐CoV‐2 main protease inhibitors

Published:2021-07-02 Issue:4 Volume:98 Page:604-619
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Ahmad Sarfraz¹,Usman Mirza Muhammad²,Yean Kee Lee¹,Nazir Mamoona³,Abdul Rahman Noorsaadah¹,Trant John F.²,Abdullah Iskandar¹

Affiliation:

1. Drug Design Development Research Group Department of Chemistry Faculty of Science Universiti Malaya Kuala Lumpur Malaysia

2. Department of Chemistry and Biochemistry University of Windsor Windsor ON Canada

3. Department of Pharmacy The University of Lahore Lahore Pakistan

Funder

Universiti Malaya

Natural Sciences and Engineering Research Council of Canada

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13914

Reference50 articles.

1. X-Ray Crystallography and its Role in Understanding the Physicochemical Properties of Pharmaceutical Cocrystals

2. Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches

3. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

4. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

5. Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor;Current Medicinal Chemistry;2024-11

2. Exploring Marine Sponge Metabolites as Promising Leads for Alzheimer's Disease: Virtual Screening, ADMET Analysis, and Molecular Dynamics Simulations;BIOMED BIOTECH RES J;2023

3. In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods;International Journal of Molecular Sciences;2023-05-06

4. Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study;Journal of Pharmaceutical Analysis;2023-05

5. Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro;Journal of Molecular Structure;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3